Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial. [electronic resource]
Producer: 20110503Description: 208-11 p. digitalISSN:- 1878-4216
- Adult
- Antidepressive Agents, Tricyclic -- therapeutic use
- Antipsychotic Agents -- therapeutic use
- Cognition Disorders -- drug therapy
- Double-Blind Method
- Drug Synergism
- Female
- Humans
- Male
- Mianserin -- analogs & derivatives
- Middle Aged
- Mirtazapine
- Psychiatric Status Rating Scales
- Retrospective Studies
- Risperidone -- therapeutic use
- Schizophrenia -- complications
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.